Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal inhalation of Pulmozyme in patients with cystic fibrosis and chronic rhinosinusitis
2007-001548-36Phase 3Completed
- Sponsor
- Friedrich Schiller University Jena
- Start
- Jul 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of dornase alfa in cystic fibrosis (CF) and chronic rhinosinusitis (CRS) (2 arms), sponsored by Friedrich Schiller University Jena. Started Jul 2009; status: completed.
02
Drugs
dornase alfa
03
Conditions
cystic fibrosis (CF)chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on 2007-001548-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001548-36.